| Progress, opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics D Yang, W Zhang, H Zhang, F Zhang, L Chen, L Ma, LM Larcher, S Chen, ... Theranostics 10 (8), 3684, 2020 | 744 | 2020 |
| Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development T Wang, C Chen, LM Larcher, RA Barrero, RN Veedu Biotechnology advances 37 (1), 28-50, 2019 | 453 | 2019 |
| Locked nucleic acids: promising nucleic acid analogs for therapeutic applications RN Veedu, J Wengel Chemistry & biodiversity 7 (3), 536-542, 2010 | 290 | 2010 |
| Systematic screening of commonly used commercial transfection reagents towards efficient transfection of single-stranded oligonucleotides T Wang, LM Larcher, L Ma, RN Veedu Molecules 23 (10), 2564, 2018 | 221 | 2018 |
| Locked nucleic acid as a novel class of therapeutic agents RN Veedu, J Wengel RNA biology 6 (3), 321-323, 2009 | 149 | 2009 |
| Recent advances in oligonucleotide therapeutics in oncology H Xiong, RN Veedu, SD Diermeier International Journal of Molecular Sciences 22 (7), 3295, 2021 | 133 | 2021 |
| In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies F Lipi, S Chen, M Chakravarthy, S Rakesh, RN Veedu RNA biology 13 (12), 1232-1245, 2016 | 115 | 2016 |
| Type 2 diabetes mellitus: limitations of conventional therapies and intervention with nucleic acid-based therapeutics GR Kokil, RN Veedu, GA Ramm, JB Prins, HS Parekh Chemical Reviews 115 (11), 4719-4743, 2015 | 103 | 2015 |
| G-rich VEGF aptamer with locked and unlocked nucleic acid modifications exhibits a unique G-quadruplex fold M Marušič, RN Veedu, J Wengel, J Plavec Nucleic Acids Research 41 (20), 9524-9536, 2013 | 99 | 2013 |
| Polymerase chain reaction and transcription using locked nucleic acid nucleotide triphosphates RN Veedu, B Vester, J Wengel Journal of the American Chemical Society 130 (26), 8124-8125, 2008 | 94 | 2008 |
| Enzymatic incorporation of LNA nucleotides into DNA strands RN Veedu, B Vester, J Wengel ChemBioChem 8 (5), 490-492, 2007 | 93 | 2007 |
| Antisense oligonucleotides targeting angiogenic factors as potential cancer therapeutics BT Le, P Raguraman, TR Kosbar, S Fletcher, SD Wilton, RN Veedu Molecular Therapy-Nucleic Acids 14, 142-157, 2019 | 84 | 2019 |
| Rapid one-step selection method for generating nucleic acid aptamers: Development of a DNA aptamer against α-bungarotoxin LH Lauridsen, HA Shamaileh, SL Edwards, E Taran, RN Veedu Public Library of Science 7 (7), e41702, 2012 | 75 | 2012 |
| Development of nucleic acid aptamer-based lateral flow assays: A robust platform for cost-effective point-of-care diagnosis T Wang, L Chen, A Chikkanna, S Chen, I Brusius, N Sbuh, RN Veedu Theranostics 11 (11), 5174, 2021 | 74 | 2021 |
| Locked nucleic acid nucleoside triphosphates and polymerases: on the way towards evolution of LNA aptamers RN Veedu, J Wengel Molecular BioSystems 5 (8), 787-792, 2009 | 74 | 2009 |
| Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers S Dawar, N Singh, RK Kanwar, RL Kennedy, RN Veedu, SF Zhou, ... Drug Discovery Today 18 (23-24), 1292-1300, 2013 | 72 | 2013 |
| Enzymatic recognition of 2′‐modified ribonucleoside 5′‐triphosphates: Towards the evolution of versatile aptamers LH Lauridsen, JA Rothnagel, RN Veedu ChemBioChem 13 (1), 19-25, 2012 | 71 | 2012 |
| Efficient enzymatic synthesis of LNA-modified DNA duplexes using KOD DNA polymerase RN Veedu, B Vester, J Wengel Organic & biomolecular chemistry 7 (7), 1404-1409, 2009 | 67 | 2009 |
| Nucleic acid-based aptamers: applications, development and clinical trials J R Kanwar, K Roy, N G Maremanda, K Subramanian, R N Veedu, ... Current Medicinal Chemistry 22 (21), 2539-2557, 2015 | 59 | 2015 |
| Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition SL Edwards, V Poongavanam, JR Kanwar, K Roy, KM Hillman, N Prasad, ... Chemical Communications 51 (46), 9499-9502, 2015 | 56 | 2015 |
Bao T. LePrincipal ScientistAdresse e-mail validée de ragebiotech.com
